Antibacterial activity studies of plasma polymerised cineole films

2014 ◽  
Vol 2 (31) ◽  
pp. 4993-5002 ◽  
Author(s):  
Adoracion Pegalajar-Jurado ◽  
Christopher D. Easton ◽  
Katie E. Styan ◽  
Sally L. McArthur

Costs associated with bacterial infections in medical devices exceed $US 30 billion each year in the United States alone due to device revisions and patient treatment.

Author(s):  
Patricia J. Zettler ◽  
Erika Lietzan

This chapter assesses the regulation of medical devices in the United States. The goal of the US regulatory framework governing medical devices is the same as the goal of the framework governing medicines. US law aims to ensure that medical devices are safe and effective for their intended uses; that they become available for patients promptly; and that manufacturers provide truthful, non-misleading, and complete information about the products. US medical device law is different from US medicines law in many ways, however, perhaps most notably because most marketed devices do not require pre-market approval. The chapter explores how the US Food and Drug Administration (FDA) seeks to accomplish its mission with respect to medical devicecough its implementation of its medical device authorities. It starts by explaining what constitutes a medical device and how the FDA classifies medical devices by risk level. The chapter then discusses how medical devices reach the market, the FDA's risk management tools, and the rules and incentives for innovation and competition. It concludes by exploring case studies of innovative medical technologies that challenge the traditional US regulatory scheme to consider the future of medical device regulation.


PEDIATRICS ◽  
1957 ◽  
Vol 20 (5) ◽  
pp. 918-919
Author(s):  
AIMS C. MCGUINNESS

I certainly agree with Dr. Dietrich that Asian influenza thus far has been a mild disease and not too serious a problem for the individual. Dr. Burney has pointed this out on a number of occasions, as, for example, in his remarks before the State and Territorial Health Officers on August 27. I agree, too, that the availability of antibiotics to deal with secondary bacterial infections should, to a great extent, minimize the severity of any epidemic in the United States.


PEDIATRICS ◽  
1972 ◽  
Vol 50 (5) ◽  
pp. 833-833
Author(s):  
John D. Nelson

Almost two years ago a group of eminent international authorities in the field of infectious diseases gathered near Cologne, Germany, for a week of reflection and discussion concerning the changing patterns of bacterial infections in recent decades and the possible reasons for the changes. The United States was represented by Drs. M. Finland and E. H. Kass of Boston, F. Daschner of Los Angeles, and A. von Graevenitz of New Haven. Other scientists were from Germany, France, Sweden, Great Britain, Switzerland, and Denmark.


2012 ◽  
Vol 366 (9) ◽  
pp. 848-855 ◽  
Author(s):  
Daniel B. Kramer ◽  
Shuai Xu ◽  
Aaron S. Kesselheim

Sign in / Sign up

Export Citation Format

Share Document